Navigation Links
Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
Date:3/19/2013

not a description of historical facts are forward-looking statements that are based on the Company's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding the Company's development plans for MST-188, including in sickle cell disease, acute limb ischemia, and other indications, and plans for protecting its intellectual property related to MST-188, as well as the timing of activities related to those plans.  Among the factors that could cause or contribute to material differences between the Company's actual results and the expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the potential for delays in the commencement or completion of clinical studies, including as a result of difficulties in obtaining regulatory agency agreement on clinical development plans or clinical study design, opening trial sites, enrolling study subjects, manufacturing clinical trial material, completing manufacturing process development activities, and being subject to a "clinical hold"; the risk of suspension or termination of a clinical study, including due to lack of adequate funding or patient safety concerns; the potential for institutional review boards or the FDA or other regulatory agencies to require additional nonclinical or clinical studies prior to initiation of planned phase 2 clinical studies of MST-188 in any particular indication in which the Company determines to develop MST-188, including acute limb ischemia, which likely would increase the total time and cost of development in the indication; the risk that clinical studies of MST-188 are not successfully executed and/or do not successfully demonstrate its safety or efficacy; the risk that, even if clinical studies are successful, the FDA determines they are not sufficient to support a new drug application; the risk that even if clinical studies of MST-188 in one indication are s
'/>"/>
SOURCE Mast Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Achieves ISO 13485 Certification
2. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3. Echo Therapeutics Appoints Robert Doman to Board of Directors
4. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
5. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
6. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
7. PTC Therapeutics Closes $60 Million Private Financing
8. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
9. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
10. Todays Research on PDL BioPharma, Dendreon, Medivation, ACADIA Pharma, and Cell Therapeutics
11. Halozyme Therapeutics to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , 17 settembre 2014 Hologic, Inc. ... il lancio in Europa del Tomcat, un nuovo ... una piattaforma multifunzionale completamente automatizzata, progettata per semplificare ... ed i rischi di errore legati alla gestione ... strumento Tomcat di Hologic riduce il carico di ...
(Date:9/16/2014)... Sept. 16, 2014 This report analyzes the worldwide ... Product Segments: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. ... and Farm Animals. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided for the ...
(Date:9/16/2014)... -- A study led by St. Jude Children,s ... threshold below which male childhood cancer survivors are likely ... September 17 edition of the journal Lancet Oncology ... highest risk for reduced sperm production as adults, researchers ... fertility preservation methods such as sperm banking. ...
Breaking Medicine Technology:Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 3Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11Global Animal Medication Industry 12Global Animal Medication Industry 13Global Animal Medication Industry 14Global Animal Medication Industry 15Global Animal Medication Industry 16Global Animal Medication Industry 17Global Animal Medication Industry 18Global Animal Medication Industry 19Global Animal Medication Industry 20Global Animal Medication Industry 21Global Animal Medication Industry 22Global Animal Medication Industry 23Global Animal Medication Industry 24Global Animal Medication Industry 25Global Animal Medication Industry 26Improved risk identification will aid fertility preservation in young male cancer patients 2Improved risk identification will aid fertility preservation in young male cancer patients 3Improved risk identification will aid fertility preservation in young male cancer patients 4
... Oct. 11, 2011 I-Flow announced ... national purchasing agreement by HealthTrust Purchasing Group, L.P. ... agreement covers I-Flow,s flagship ON-Q® products for incisional, ... ON-Q® PainBuster®, ON-Q® SilverSoaker™ Catheters and ON-Q® disposable ...
... Utah, Oct. 11, 2011 Merit Medical Systems, Inc. ... marketer of proprietary disposable medical devices used in interventional ... announced today that the Company will release its financial ... after the close of the stock market on Tuesday, ...
Cached Medicine Technology:I-Flow LLC, a Kimberly-Clark Health Care Company Announces Agreement for ON-Q® Products With HealthTrust Purchasing Group 2
(Date:9/17/2014)... (PRWEB) September 17, 2014 ... Access Management (IdM/IAM) solutions and Boston Software ... their business partner relationship. Under the ... technology to automate functionality within its identity ... Software Systems provides healthcare automation platforms that ...
(Date:9/17/2014)... UK, September 17, 2014 The International Journal of ... opened up its archive of previously published content: after 24 ... A key aim of the IJS is to ... that by making these articles available to all will improve ... of IJS said, "The journal has always been ...
(Date:9/17/2014)... A recent study of 54,000 surgical patients ... these patients developed surgical site infections (SSIs), with 0.8% labeled ... average difference for each patient with an SSI and those ... by Marin Schweizer, PhD, of the Iowa City VA Health ... costs for the hospitals were 1.25 times more for patients ...
(Date:9/17/2014)... 2014 The probability of prostate cancer ... screening and examination, a healthy diet could decrease the ... Epicure with the Chef MDs, renowned Chef Vikram ... to prepare a delicious Fish Moilee. , Dr. Rusilko ... influence risk of prostate cancer, uncommonly found in Asian ...
(Date:9/17/2014)... Acceleratio Ltd., an innovative software ... 6.0 of Server Monitoring Toolkit , a ... reporting. It brings real-time server monitoring via a ... and enhanced features that significantly improve troubleshooting and ... provides agentless data collection, a user-friendly interface, and ...
Breaking Medicine News(10 mins):Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 2Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 3Health News:Tools4ever Partners with Boston Software Systems to Automate Identity and Password Management 4Health News:Three Ways to Minimize Costs Associated with Surgical Site Infections 2Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3
... BURLINGTON, N.J., Aug. 5 Most people over the age ... to focus on nearby objects. Although this age related phenomena is ... Kajita Clinic in Tokyo, Japan and published in March, 2009 has ... in older subjects (mean age of 53.9 +/- 5.1 years) with ...
... , , WASHINGTON, Aug. ... its latest report on effective emergency management for people with ... Association of Emergency Managers, 2009 National Conference on ... Corps at the Hyatt Regency Crystal City Hotel, 2799 ...
... , Goal to Distinguish Science Questions from Policy ... Advisory Committees Solely of Members with Relevant Scientific Expertise; Improve ... 5 A bipartisan panel of top scientific and regulatory ... federal agencies to make specific changes in the regulatory process ...
... , , CINCINNATI, Aug. 5 ... STRM ) today announced that, in an effort to further ... independent, non-management director as the Company,s Chairman of the Board. ... current independent member of the Company,s Board of Directors, as Chairman ...
... , , BOULDER, Colo., Aug. 5 ... Organic Center) strongly refute the claim made by Dr. Alan Dangour and ... important., Left unchallenged, the U.K. team,s study and Dr. Dangour,s remarks ... organic food. Among the multiple missteps in the FSA,s analysis are ...
... , , CARLSBAD, ... their DNA recovery product, GenSolve(TM), is enabling independent groups, from diverse ... for microarray based genomic analysis and Illumina iSelect based genotyping. , ... 2 :107 (16 June 2009) and BMC Genetics 2009, 10 ...
Cached Medicine News:Health News:The Reduction of Eye Fatigue Improves Vision in Older Subjects 2Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 2Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 3Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 4Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 5Health News:Bipartisan Panel of Industry, NGO and Academic Experts Proposes New Rules for Science in Federal Regulation 6Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 2Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 3Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 4Health News:Streamline Health Appoints Jon Phillips Chairman of the Board of Directors 5Health News:The Organic Center Refutes Misleading Nutritional Claims Made by United Kingdom's Food Standards Agency (FSA) in Agency Report on Health Value of Organic Foods 2Health News:GenVault's GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots 2Health News:GenVault's GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots 3
DIX foreign body spud 4 3/4 inches, 1.7 x 15 mm blade....
... MMA/VP material and has a high water content ... the base curve and total diameter as specified ... a power range of -30.00DS to +30.00DS,Simplon Bandage ... therapeutic applications including the controlled on-eye delivery of ...
Foreign body spud very thin, lightly curved and rounded tip....
... Manufactured from premium ... with high oxygen permeability. ... design. Recommended for the ... erosions and abrasions. bullous ...
Medicine Products: